Healthcare -
Biotechnology - NASDAQ - US
$ 0.214
5.52 %
$ 14 M
Market Cap
-0.14
P/E
LYRA - RESEARCH & DEVELOPMENT
Research & Development LYRA - Lyra Therapeutics, Inc.
48 M
LAST VALUE
27.18%
2 YEAR CAGR
57.38%
5 YEAR CAGR
0.00%
10 YEAR CAGR